73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Study identifies link between DNA-protein binding, cancer onset

Study identifies link between DNA-protein binding, cancer onset

byStanford University Medical CenterResearchers at the Stanford University School of Medicine and their collaborators at other institutions have identified a link between how proteins bind to ou

Study identifies link between DNA-protein binding, cancer onset

byStanford University Medical CenterResearchers at the Stanford University School of Medicine and their collaborators at other institutions have identified a link between how proteins bind to ou
CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

by Delthia Ricks , Medical XpressCancer cell during cell division. Credit: National Institutes of HealthA deeper understanding of the immune system's role in controlling cancer has helped drive &q

CAR T cell therapy: On the cusp of 'an immunotherapy revolution'?

by Delthia Ricks , Medical XpressCancer cell during cell division. Credit: National Institutes of HealthA deeper understanding of the immune system's role in controlling cancer has helped drive &q
First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with

First-in-human clinical trial of CAR T cell therapy with new binding mechanism shows promising early responses

by Perelman School of Medicine at the University of PennsylvaniaSafety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with
Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre

Amivantamab-lazertinib ups survival in EGFR-mutated advanced lung cancer

by Elana GotkineFor patients with EGFR-mutated advanced non-small cell lung cancer (NSCLC), amivantamab-lazertinib yields improved progression-free survival compared with osimertinib as first-line tre
Researchers create a drug to extend the lives of men with prostate cancer

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye

Researchers create a drug to extend the lives of men with prostate cancer

by Stuart Wolpert,University of California, Los AngelesMicrograph showing prostatic acinar adenocarcinoma (the most common form of prostate cancer) Credit: Wikipedia,CC BY-SA 3.0Fifteen ye
The new prostate cancer blood test with 94 per cent accuracy

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate

The new prostate cancer blood test with 94 per cent accuracy

byUniversity of East AngliaProstate cancer cells. Credit: NIH Image GalleryResearchers at the University of East Anglia have helped develop a new blood test to detect prostate cancer with greate
New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s

New biotechnology combines targeted and immune therapies to kill treatment-resistant cancer cells

byNYU Langone HealthBinding profiles soto-p7/A03 (top row) and p7WT/A03 (bottom row) of clone R011 (left column), the naïve deep mutational scanning library (middle column), and the pool after s
Bacterium may decrease effectiveness of immunotherapy

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.

Bacterium may decrease effectiveness of immunotherapy

by Béatrice St-Cyr-Leroux,University of MontrealAssociation between the H. pylori seropositivity status and clinical outcomes in 97 patients with advanced melanoma. A. Stacked barplot between H.
Updates: MET targeted therapy for EXON 14 mutations in lung cancer

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published

Updates: MET targeted therapy for EXON 14 mutations in lung cancer

by Impact Journals LLCCredit: Pixabay/CC0 Public DomainAnew editorial papertitled "Latest updates on MET targeted therapy for EXON 14 mutations in lung cancer" has been published
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons
Improving next-generation cancer treatments with cryoimmunotherapy

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut

Improving next-generation cancer treatments with cryoimmunotherapy

by Olivia Dimmer,Northwestern UniversityCredit:ACS Nano(2024). DOI: 10.1021/acsnano.4c05809Northwestern Medicine scientists have developed a more effective method of delivering a cut
Exposure to chemical in Roundup increases risk for cancer: study

Exposure to chemical in Roundup increases risk for cancer: study

by Jackson Holtz,University of WashingtonTimeline that shows the growth in glyphosate usage worldwide (left) and key human epidemiological studies on the herbicide (right). Credit: University of

Exposure to chemical in Roundup increases risk for cancer: study

by Jackson Holtz,University of WashingtonTimeline that shows the growth in glyphosate usage worldwide (left) and key human epidemiological studies on the herbicide (right). Credit: University of